136 related articles for article (PubMed ID: 33674357)
1. Transient Depletion of CD4
Aoki H; Ueha S; Shichino S; Ogiwara H; Shitara K; Shimomura M; Suzuki T; Nakatsura T; Yamashita M; Kitano S; Kuroda S; Wakabayashi M; Kurachi M; Ito S; Doi T; Matsushima K
Cancer Immunol Res; 2021 Jun; 9(6):624-636. PubMed ID: 33674357
[TBL] [Abstract][Full Text] [Related]
2. First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors.
Shitara K; Ueha S; Shichino S; Aoki H; Ogiwara H; Nakatsura T; Suzuki T; Shimomura M; Yoshikawa T; Shoda K; Kitano S; Yamashita M; Nakayama T; Sato A; Kuroda S; Wakabayashi M; Nomura S; Yokochi S; Ito S; Matsushima K; Doi T
J Immunother Cancer; 2019 Jul; 7(1):195. PubMed ID: 31340866
[TBL] [Abstract][Full Text] [Related]
3. TCR Repertoire Analysis Reveals Mobilization of Novel CD8
Aoki H; Ueha S; Shichino S; Ogiwara H; Hashimoto SI; Kakimi K; Ito S; Matsushima K
Front Immunol; 2018; 9():3185. PubMed ID: 30733724
[TBL] [Abstract][Full Text] [Related]
4. Greater extent of blood-tumor TCR repertoire overlap is associated with favorable clinical responses to PD-1 blockade.
Aoki H; Ueha S; Nakamura Y; Shichino S; Nakajima H; Shimomura M; Sato A; Nakatsura T; Yoshino T; Matsushima K
Cancer Sci; 2021 Aug; 112(8):2993-3004. PubMed ID: 34014607
[TBL] [Abstract][Full Text] [Related]
5. Repertoire Remodeling through CD4
Yao W; Satpathy AT
Cancer Immunol Res; 2021 Jun; 9(6):601. PubMed ID: 34365414
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
[TBL] [Abstract][Full Text] [Related]
7. TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis.
Du G; Chen CY; Shen Y; Qiu L; Huang D; Wang R; Chen ZW
J Immunol; 2010 Oct; 185(7):3940-7. PubMed ID: 20805423
[TBL] [Abstract][Full Text] [Related]
8. Proportional Tumor Infiltration of T Cells
Tsunoda M; Aoki H; Shimizu H; Shichino S; Matsushima K; Ueha S
Front Immunol; 2021; 12():744381. PubMed ID: 34759926
[TBL] [Abstract][Full Text] [Related]
9. Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy.
Turcotte S; Gros A; Tran E; Lee CC; Wunderlich JR; Robbins PF; Rosenberg SA
Clin Cancer Res; 2014 Jan; 20(2):331-43. PubMed ID: 24218514
[TBL] [Abstract][Full Text] [Related]
10. Clonality of CD4
Arakawa A; Vollmer S; Tietze J; Galinski A; Heppt MV; Bürdek M; Berking C; Prinz JC
Front Immunol; 2019; 10():1336. PubMed ID: 31275310
[TBL] [Abstract][Full Text] [Related]
11. Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.
Aoki H; Shichino S; Matsushima K; Ueha S
Front Immunol; 2022; 13():807696. PubMed ID: 35154125
[TBL] [Abstract][Full Text] [Related]
12. Normal CD4 T-cell receptor repertoire in tonsillar tissue despite perturbed repertoire in peripheral blood in HIV-1 infected individuals.
Mugnaini EN; Syversen AM; Sannes M; Freng A; Brinchmann JE
AIDS; 1999 Dec; 13(18):2507-13. PubMed ID: 10630519
[TBL] [Abstract][Full Text] [Related]
13. Anti-GITR Antibody Treatment Increases TCR Repertoire Diversity of Regulatory but not Effector T Cells Engaged in the Immune Response Against B16 Melanoma.
Scirka B; Szurek E; Pietrzak M; Rempala G; Kisielow P; Ignatowicz L; Miazek A
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):553-564. PubMed ID: 28638937
[TBL] [Abstract][Full Text] [Related]
14. Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts.
Aschauer C; Jelencsics K; Hu K; Heinzel A; Gregorich MG; Vetter J; Schaller S; Winkler SM; Weinberger J; Pimenov L; Gualdoni GA; Eder M; Kainz A; Troescher AR; Regele H; Reindl-Schwaighofer R; Wekerle T; Huppa JB; Sykes M; Oberbauer R
Front Immunol; 2021; 12():750005. PubMed ID: 34721420
[TBL] [Abstract][Full Text] [Related]
15. TCR repertoire intratumor heterogeneity of CD4
Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
[TBL] [Abstract][Full Text] [Related]
16. Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient.
Knutson KL; Disis ML
Hum Immunol; 2002 Jul; 63(7):547-57. PubMed ID: 12072190
[TBL] [Abstract][Full Text] [Related]
17. Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).
Kay N; Leong T; Kyle RA; Greipp P; Van Ness B; Bone N; Oken MM
Leuk Lymphoma; 1999 Mar; 33(1-2):127-33. PubMed ID: 10194129
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia.
Rezvany MR; Tehrani MJ; Karlsson C; Lundin J; Rabbani H; Osterborg A; Mellstedt H
Br J Haematol; 2006 Nov; 135(4):475-85. PubMed ID: 16995884
[TBL] [Abstract][Full Text] [Related]
19. The distribution of human TCR junctional region lengths shifts with age in both CD4 and CD8 T cells.
Hall MA; Reid JL; Lanchbury JS
Int Immunol; 1998 Oct; 10(10):1407-19. PubMed ID: 9796907
[TBL] [Abstract][Full Text] [Related]
20. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion.
Schnittman SM; Denning SM; Greenhouse JJ; Justement JS; Baseler M; Kurtzberg J; Haynes BF; Fauci AS
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7727-31. PubMed ID: 2217206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
